Marshall Wace LLP Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Marshall Wace LLP purchased a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 77,581 shares of the company’s stock, valued at approximately $260,000. A number of other hedge funds also recently bought and sold shares of the stock. Barclays PLC increased its […]
Marshall Wace LLP purchased a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 77,581 shares of the company’s stock, valued at approximately $260,000. A number of other hedge funds also recently bought and sold shares of the stock. Barclays PLC increased its […]
